During this season, we wish you a holiday filled with joy and hope for the new year.
Posts by Elekta
When #radonc professionals met outside London for the @mrlconsortium.bsky.social meeting, the energy was unmistakable. It wasn't just their 20th gathering, it was a celebration of how far MRgRT has come and where it's headed. Read what made it so special ➡️ bit.ly/4iFOAyy
The @mrlconsortium.bsky.social Consortium meeting brought together experts to share cutting-edge clinical insights, and now you can catch up! Join us to hear from clinicians on MRgRT advancements, explore established clinical workflows and ongoing trials ➡️ bit.ly/4ovtiVA
At the 20th Consortium meeting, it was inspiring to connect with so many members and see the progress being made in MRgRT. We're grateful to all who contributed their expertise and enthusiasm. Until next time!
Today we awarded the best clinical, technical and young investigator abstracts. Congrats to this year's winners: Julia Peltenburg and Marlies Nowee, Xiangyu Zhang and Tariq Lalmahomed for their work in motion management, prostate cancer QoL and liver oligometastases treatment.
Last week we hosted the MR-Linac Consortium meeting, bringing together 100+ member institutions. The discussions spanned clinical data, technical innovation and shared experience, all aimed at improving MR-guided and OART. We're so proud of how this group continues to improve care.
In honor of Marie Curie's birthday tomorrow, don't forget to share a photo of something that captures what it means to you to be in radiation oncology (a linac 🤳, prepping for a brachy procedure, treatment planning, etc) with the #WeWhoCurie hashtag! ☢️
The MR-Linac Consortium meeting kicked off today with 300+ members focused on sharing clinical data, research and the future of MRgRT. Huge thanks to our 2025 Organization Committee and Clinical Steering Committee Chair, Dr. Alison Tree, for driving MR-adaptive forward.
55 years ago, Maggie was diagnosed with a rare brain tumor. Due to its location, drs told her she’d likely never have children. She underwent Gamma Knife, which had a profound impact on her life. The procedure not only treated the tumor but allowed her to give birth to a daughter. bit.ly/43FbRdu
*Elekta Evo has CE mark and pending U.S. FDA 510(k) clearance with limited global distribution. Do not distribute this information within U.S.
In episode 6 of Spilling the RT, @xristodouleas.bsky.social offers his take on highlights from #ASTRO25, addresses the ongoing debate around protons and explains why he believes the future is adaptive. bit.ly/4qj4pyB
For more than 35 years, the Leksell Gamma Knife Society has gathered to share knowledge, collaborate and advance care. Thank you for the role each of you plays in building the evidence behind Leksell Gamma Knife. We look forward to seeing everyone next year!
We were delighted to welcome @lancasteruni.bsky.social student, Francesca Lynch Brown, to our Cornerstone campus, where she received the “Best Female Engineering Student” award. Sponsored by Elekta, the award celebrates outstanding academic excellence demonstrated by a female undergrad.
To say we're honored to welcome members of the Gamma Knife Society to Stockholm this week is an understatement. With 300+ member institutions from 50 countries, we ❤️ how this “meeting of the minds” continues to inspire collaboration, innovation and excellence in neurosurgical care.
Wishing a joyful Diwali to all who celebrate!
When five-year-old Abby was diagnosed with hypothalamic hamartoma, a benign brain lesion that causes seizures and behavioral changes, her family searched for answers. After medication failed, they turned to Gamma Knife. Read why she’s now able to enjoy childhood ➡️ bit.ly/43j0VlB.
*Elekta Evo has CE mark and is pending U.S. FDA 510(k) clearance with limited global availability. Do not distribute this information within the U.S.
In February DTZ Berlin made history as first in the 🌍 to treat patients using OART with Elekta Evo. The @umcutrecht.bsky.social team also added online adaptive to their toolkit. In @physicsworld.bsky.social read about the options Elekta offers clinics interested in implementing ART bit.ly/47r6aSE
A heartfelt thank you to everyone — both near and far — who spent time with at #ASTRO25. We are grateful for the opportunity to connect in person and look forward to seeing you next year in Boston!
Don't miss results from an analysis of patients treated during clinical implementation of CMM at @mdanderson.bsky.social.
Findings show respiratory and non-respiratory gating are feasible and effective and real-time gating is 🔑 to target coverage during beam-on. bit.ly/4nU1LNr #ASTRO25
At 2:30 p.m., Dr. Chen Wang will present the first study showing MRgART SABR for postoperative recurrent and metastatic pancreatic cancer can achieve excellent local control, minimal toxicity, consistent pain relief and maintain/improve QoL bit.ly/4gL4x5j #ASTRO25
At 12:45 in Hall F, @alongi_filippo will present clinical feasibility and safety data from 1,000 patients treated with Elekta Unity – one of the largest MR‑guided adaptive RT datasets supporting routine use across multiple disease sites. bit.ly/4gJ7i7a #ASTRO25
At 3:50, Bin Wang, PhD will present a deep learning method to generate synthetic 3.0T MR images for brain tumor ART on a 1.5T MR-Linac – enhancing image quality and anatomical detail, potentially improving tx planning and adaptation accuracy. bit.ly/4nlTWAp #ASTRO25
A study showing Unity is associated with improved QoL in men with localized prostate cancer was just presented by @whallradonc at #ASTRO25. Read how @momentumstudy.bsky.social data confirmed the use of MR-guided adaptive RT translated into improvements in urinary irritation symptoms. bit.ly/3IMQwrh
At 10:45, this #ASTRO25 session dives into emerging, evidence-based uses of RT for conditions like keloids and ventricular arrhythmias. If you're looking to expand your toolkit beyond cancer care, here's your chance to learn "how to treat and why it works"
At 10:55 Dr. William Hall will show how MR-guided adaptive RT with Unity improves patient-reported urinary symptoms in men w/ prostate cancer. MOMENTUM data confirm tracking anatomy changes and adjusting each tx session can lead to better long-term QoL #ASTRO25
Today at 8 a.m. in Hall F, don't miss Dr. Kurl Jamora from Austin Health present clinical outcomes and QoL data from an Australian cohort treated with MR-guided adaptive RT for glioblastoma, showing the approach is feasible and well tolerated. bit.ly/48JBxJ8
At 4:45 in Hall F, Shandong Cancer Hospital and Institute will report the feasibility of using MRI to guide hypofractionated RT for NSCLC, showing it improves soft tissue visualization, reduces setup error and enables precise dose delivery. bit.ly/42hFK2R #ASTRO25
Today at 2:30 PT in Hall F, don't miss @pmresearch-uhn.bsky.social present their experience using online adaptive MR-guided SBRT for central lung tumors, showing daily adaptation is achievable, improves target coverage and OAR sparing. bit.ly/46EJ2hZ #ASTRO25
Heading to the @astro-org.bsky.social annual meeting and have 15 mins? Starting Sunday, we invite you to visit Elekta booth 1407 and get inspired by one (or more) of our speakers in our clinical theater. The first presentation starts at noon PT. View the 📅 lineup here ➡️ bit.ly/46nk4ov. #ASTRO25